AzTrials
AzTrials

Critical IllnessFluid-SEANCT06034990

ICU Fluid Utilization Survey in Southeast Asia

An observational study of Critical Illness, run by Chulalongkorn University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Critical Illness
What is being tested?
10-min online survey
How many people
1,000 participants
Where
1 siteThailand
Study dates
31 Jan 2024to 30 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Physicians with specialty in Anesthesiology, Surgery, Critical care medicine, Pulmonology, Nephrology, General Medicine currently working in Surgical or Medical ICU in Southeast Asia in year 2023-2024

Who may be able to join

  • Specialty must be in Anesthesiology, Surgery, Critical Care Medicine, Pulmonology, Nephrology, Internal Medicine, General Practitioner
  • Practice must be in Southeast Asia hospitals
  • Must work in Surgical ICU, Medical ICU , and/or Mixed ICU

Who cannot join

  • 1.Physicians who worked in cardiac, neurology or pediatric ICUs

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Chulalongkorn university

    Bangkok, Bangkok, 10330

Other trials in Thailand

About this study

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia.

The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

Read the detailed description

The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia, and to determine whether co-morbidities with hypoalbuminemia, clinician specialties, hospital practice settings, geographic locations and re-imbursement limitation especially for colloids influence the practice patterns of fluid utilization in different phases in the 3 types of patients. Ultimately, the information provided by this study could also provide basic background information for the design of future clinical trials regarding fluid resuscitation strategies.

The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.

The survey will start with an inform-consent form prior to starting the survey questions which consist of 13-item questionnaire obtaining information on

  1. Demographics data of clinicians taking the survey on primary specialty, region or country of practice and hospital settings.
  2. Preferences for volume status indicators.
  3. Preferences for fluid resuscitation in 3 types of patients (1. Septic 2. bleeding but not septic 3. not bleeding and not septic) during resuscitation and optimization phase.
  4. Preferences for fluid resuscitation in the 3 types of patients with hypoalbuminemia including (1) cirrhosis (2) nephrotic syndrome (3) other significant hypoalbuminemia during resuscitation/optimization phase and stabilization phase
  5. The reasons for using colloids for volume expansion
  6. The experience of adverse reactions to albumin
  7. The awareness and importance of non-oncotic properties of albumin
  8. The impact of reimbursement for colloids on resuscitation fluid choice
Being tested
10-min online survey
Keywords
Crystalloids, Colloids, Fluid resuscitation, Intensive care unit, Sepsis, Bleeding
Medical subject headings
Critical Illness, Sepsis, Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 10-min online surveyOther

    This is a cross-sectional study. The data are collected by a 10-min online survey administered to included physicians which will be distributed via online channels such as such as official website or Facebook pages of Society of intensive care or Society of nephrology of corresponding countries.

Study groups in NCT06034990
Study groupRoleWhat they receive
Survey participantsParticipants in this cross-sectional survey will be physicians with specialty in Anesthesiology, Surgery, Critical care medicine, Pulmonology, Nephrology, General Medicine currently working in Surgical or Medical ICU in Southeast Asia in year 2023-2024
Receives: Other: 10-min online survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fluid resuscitation practice pattern

    Preferences for fluid resuscitation in 3 types of patients (1. Septic 2. bleeding but not septic 3. not bleeding and not septic) during resuscitation and optimization phase.

    Measured: 1/9/23-1/9/24

Secondary outcomes (2)
  1. Preferences for volume status indicators.

    Preferences for volume status indicators and diagnostic tools

    Measured: 1/9/23-1/9/24

  2. Fluid resuscitation practice pattern in hypoalbuminemic state

    Preferences for fluid resuscitation in the 3 types of patients with hypoalbuminemia including (1) cirrhosis (2) nephrotic syndrome (3) other significant hypoalbuminemia during resuscitation/optimization phase and stabilization phase

    Measured: 1/9/23-1/9/24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2023
  2. Study start31 Jan 2024
  3. Primary completion31 Jul 2025
  4. Study completion30 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06034990
Sponsor's protocol ID
IRB.457/66
Acronym
Fluid-SEA
Status last verified
Sep 2026
First submitted
6 Sep 2023
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Miller TE, Bunke M, Nisbet P, Brudney CS. Fluid resuscitation practice patterns in intensive care units of the USA: a cross-sectional survey of critical care physicians. Perioper Med (Lond). 2016 Jun 16;5:15. doi: 10.1186/s13741-016-0035-2. eCollection 2016.

    PubMed 27313844

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness, run by Chulalongkorn University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fluid resuscitation practice pattern (time frame: 1/9/23-1/9/24). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06034990, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in